Amlodipine Besylate Tablet
Product Images NDC 42806-055

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 42806-055). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Epic Pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Amlodipine 10mg 1000ct (Amlodipine 10mg 90s)

Amlodipine 10mg 1000ct (Amlodipine 10mg 90s)
This is a medication label for Amlodipine Besylate Tablets. It provides instructions for the storage and dispensation of the medication, as well as the recommended dosage. The medication should be stored at controlled room temperature and in a light-resistant container with a child-resistant closure. The label also contains the distributor's information, the amount of tablets included (1000), and the strength of each tablet (10mg).*
FDA Label Image

Amlodipine 2.5mg 90s

Amlodipine 2.5mg 90s
This is a medication information sheet for Amlodipine Besylate Tablets, USP with a usual dosage of 2.5 mg. It instructs to store the tablet at room temperature, dispense in an airtight and moisture-resistant container, and protect from light. The tablet contains Amiodipine Besylate, and it must be kept tightly closed and away from children. The sheet also includes a product code and distributor information.*
FDA Label Image

Amlodipine 5mg 500ct (Amlodipine 5mg 90s)

Amlodipine 5mg 500ct (Amlodipine 5mg 90s)
This text provides information about the usual dosage, storage instructions, and dispensing information for tablets containing Amiodipine Besylate and Amlodipine. It also includes a warning to keep the medication out of the reach of children and to protect it from light. The text also specifies the manufacturer and the drug code.*
FDA Label Image

Effects-on-primary-endpoint-of-amlodipine (Effects On Primary Endpoint Of Amlodipine)

FDA Label Image

Kaplan-meier-analysis (Kaplan Meier Analysis)

Kaplan-meier-analysis (Kaplan Meier Analysis)
This appears to be a statistical output from a survival analysis, but it is difficult to tell without more context. The P-value and hazard ratio suggest that there may be a significant difference between two groups in terms of survival rates, and the 5% confidence interval gives a range of possible values for the true hazard ratio. The "at risk" column likely shows the number of subjects in each group who are still being followed at each time point. However, without more information it is not possible to provide a more specific description.*
FDA Label Image

Structural Formula

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.